Skip to content
Screener

Integra LifeSciences IART Europe — Total Revenues

Other geography segments

Asia Pacific
$48.7M+2.0%
Rest of World
$20.39M+7.5%

Similar metrics at other companies

News Corporation logo
NWSEurope — Total Revenues
$457.5M+7.0%
Xerox Holdings Corporation logo
XRXEurope — Total Revenues
$531M+21.2%
EAF
EAFEurope, Middle East, Africa — Total Revenues
$49.72M-7.3%
ESP
ESPRCollaboration revenue — Total Revenues
$36.71M+22.0%
CME Group logo
CMEOther Revenue — Total Revenues
$115.6M+9.2%
Regis Corporation logo
RGSU.S. — Total Revenues
$48.55M+5.9%

Other financials

Income statement

See full
Revenue$418.8M+0.8%
Gross profit$219.7M+5.0%
Operating income$19.3M+104%
Net income$4.5M+101%
EPS (diluted)$0.06+101%

Balance sheet

See full
Cash & equivalents$214.4M-1.6%
Total debt$2.0B+3.2%
Total equity$1.0B+0.5%
Total assets$3.6B-2.8%

Cash flow

See full
Operating cash flow$22.8M+156%
CapEx$12.3M-38.9%
Free cash flow$10.5M+193%

Valuation

See full
Market cap$1.33B+38.0%
Enterprise value$3.08B+16.2%
P/S0.8×+0.2×

Profitability

See full
Gross margin52.5%-0.1pp
Operating margin2.6%+1.3pp
Net margin-0.4%
FCF margin3.8%-6.3pp

Returns & leverage

See full
Return on equity-0.7%
Debt / equity1.9×+0.1×
Current ratio3.6×+2.4×

Where this comes from

Reported directly by Integra LifeSciences in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Integra LifeSciences’s 10-Q, filed July 29, 2026.

Filed
Jul 29, 2026, 4:03 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000917520-26-000058
Dollars in thousandsThree Months Ended June 30, 2026Three Months Ended June 30, 2025Six Months Ended June 30, 2026Six Months Ended June 30, 2025
United States$307,099$306,308$596,479$588,525
Europe42,57242,59482,53577,920
Asia Pacific48,69747,73293,90892,837
Rest of World20,39318,97137,75738,976
Total Revenues$418,761$415,605$810,679$798,258

Item 1. Financial Statements

FAQ

What is Integra LifeSciences's europe — total revenues?
Integra LifeSciences (IART) reported europe — total revenues of $42.57M in Q2 2026.
How has Integra LifeSciences's europe — total revenues changed year-over-year?
Integra LifeSciences's europe — total revenues decreased by 0.1% year-over-year, from $42.59M to $42.57M.
What is the long-term trend for Integra LifeSciences's europe — total revenues?
Over 4 years (2021 to 2025), Integra LifeSciences's europe — total revenues has grown at a -4.0% compound annual growth rate (CAGR), from $191.33M to $162.67M.
What does europe — total revenues mean?
This metric represents the total net revenue generated from the sale of medical devices and regenerative technology products within the European geographic market. It serves as a key indicator of the company's regional market penetration and the demand for its specialty surgical and tissue technology portfolios. Tracking this figure allows investors to assess the performance and growth trajectory of the company's international operations outside of its domestic base.

Ask your AI about Integra LifeSciences's europe — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude